ArticleFrontiers in neuroscience2025

Assessment of the impact of reconstitution therapies-cladribine tablets and alemtuzumab-on the atrophy progression among patients with relapse-remitting multiple sclerosis.

Aleksandra Pogoda-Wesołowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.